Skip to content

Precigen PGEN EBITDA margin

EBITDA margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
27.2%-2.2pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
27.9%-2.8pp
Gilead Sciences logo
Gilead SciencesGILD
36.1%+6.2pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-543.2%-271pp
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-712%-201pp
Arrowhead Research logo
Arrowhead ResearchARWR
-31.6%+105pp

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

Based on trailing twelve months.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's EBITDA margin?
Precigen (PGEN) reported EBITDA margin of -2,807.8% in Q1 2025.
What is the long-term trend for Precigen's EBITDA margin?
Over 3 years (2020 to 2024), Precigen's EBITDA margin has grown at a 267.6% compound annual growth rate (CAGR), from -67% to -3,324.9%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.